1
|
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
|
Medicine (Baltimore)
|
2003
|
4.00
|
2
|
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
|
Arthritis Rheum
|
2002
|
3.96
|
3
|
Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis.
|
J Rheumatol
|
2009
|
2.19
|
4
|
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
|
Rheumatology (Oxford)
|
2013
|
2.14
|
5
|
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
|
J Rheumatol
|
2003
|
1.99
|
6
|
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
|
Arthritis Rheum
|
2004
|
1.89
|
7
|
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
|
J Rheumatol
|
2011
|
1.52
|
8
|
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists?
|
Arthritis Care Res (Hoboken)
|
2012
|
1.46
|
9
|
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.
|
Arthritis Rheum
|
2006
|
1.21
|
10
|
The pathogenetic role of HLA-B27 and its subtypes.
|
Autoimmun Rev
|
2006
|
1.19
|
11
|
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al.
|
Arthritis Care Res (Hoboken)
|
2013
|
1.07
|
12
|
Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia.
|
Arthritis Rheum
|
2007
|
1.05
|
13
|
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients.
|
Rheumatology (Oxford)
|
2011
|
1.04
|
14
|
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients.
|
Rheumatology (Oxford)
|
2012
|
1.03
|
15
|
A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403.
|
Arthritis Rheum
|
2007
|
1.03
|
16
|
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
|
Autoimmun Rev
|
2012
|
0.98
|
17
|
Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region.
|
Rheumatology (Oxford)
|
2010
|
0.96
|
18
|
Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies.
|
Arthritis Rheum
|
2005
|
0.89
|
19
|
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study.
|
Clin Exp Rheumatol
|
2011
|
0.86
|
20
|
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study.
|
Rheumatology (Oxford)
|
2010
|
0.85
|
21
|
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis.
|
Arthritis Rheum
|
2003
|
0.85
|
22
|
Vitamin D levels and potential impact in systemic sclerosis.
|
Clin Exp Rheumatol
|
2011
|
0.82
|
23
|
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
|
Clin Exp Rheumatol
|
2011
|
0.81
|
24
|
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies.
|
Ann N Y Acad Sci
|
2007
|
0.81
|
25
|
Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis.
|
J Rheumatol Suppl
|
2012
|
0.81
|
26
|
HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia.
|
Arthritis Res Ther
|
2009
|
0.81
|
27
|
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study.
|
Joint Bone Spine
|
2011
|
0.81
|
28
|
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues.
|
Clin Exp Rheumatol
|
2011
|
0.80
|
29
|
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.
|
Drug Dev Res
|
2014
|
0.79
|
30
|
Etanercept in spondyloarthropathies. Part I: current evidence of efficacy.
|
Clin Exp Rheumatol
|
2011
|
0.79
|
31
|
CD8+ T-cell mediated self-reactivity in HLA-B27 context as a consequence of dual peptide conformation.
|
Clin Immunol
|
2010
|
0.78
|
32
|
The growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis.
|
Semin Arthritis Rheum
|
2011
|
0.77
|
33
|
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
|
Clin Ther
|
2007
|
0.77
|
34
|
The origin of Behçet's disease geoepidemiology: possible role of a dual microbial-driven genetic selection.
|
Clin Exp Rheumatol
|
2014
|
0.77
|
35
|
Osteoarthritis of the zygapophysial joints: efficacy of percutaneous radiofrequency neurotomy in the treatment of lumbar facet joint syndrome.
|
Clin Exp Rheumatol
|
2012
|
0.76
|
36
|
Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes.
|
PLoS One
|
2012
|
0.76
|
37
|
HLA-B27 and free HLA class I heavy chains in ankylosing spondylitis.
|
J Rheumatol
|
2003
|
0.75
|
38
|
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests.
|
Arthritis Res Ther
|
2013
|
0.75
|
39
|
HLA-B*2709 and spondylarthropathies: comment on the concise communication by Olivieri et al.
|
Arthritis Rheum
|
2003
|
0.75
|
40
|
Multiple septic bursitis and spontaneous Achilles tendon tear in systemic lupus erythematosus.
|
J Rheumatol
|
2010
|
0.75
|
41
|
Post-streptococcal reactive arthritis associated with group G streptococcal pharyngitis.
|
J Clin Rheumatol
|
2010
|
0.75
|
42
|
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
|
BioDrugs
|
2014
|
0.75
|
43
|
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.
|
Clin Exp Rheumatol
|
2014
|
0.75
|
44
|
Familial chilblain and late contractural arachnodactyly: a novel association?
|
Joint Bone Spine
|
2009
|
0.75
|
45
|
Myocardial positron emission tomography/computed tomography scan revealing right coronary artery involvement in large vessel vasculitis.
|
J Rheumatol
|
2012
|
0.75
|